Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001–2006
- 25 August 2009
- journal article
- research article
- Published by Elsevier BV in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 20 (8), 583-590
- https://doi.org/10.1016/j.numecd.2009.05.012
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Gammaglutamyltransferase in ESRD as a predictor of all-cause and cardiovascular mortality: another facet of oxidative stress burdenKidney International, 2008
- Rapid Kidney Function Decline and Mortality Risk in Older AdultsJAMA Internal Medicine, 2008
- Fractions of plasma gamma-glutamyltransferase in healthy individuals: Reference valuesClinica Chimica Acta; International Journal of Clinical Chemistry, 2008
- Increased Risk of CKD among Type 2 Diabetics with Nonalcoholic Fatty Liver DiseaseJournal of the American Society of Nephrology, 2008
- Non-alcoholic fatty liver disease: The mist gradually clearsJournal of Hepatology, 2008
- Renal Insufficiency and Mortality in Patients with Known or Suspected Coronary Artery DiseaseJournal of the American Society of Nephrology, 2008
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- Exploring Secular Trends in the Likelihood of Receiving Treatment for End-Stage Renal DiseaseClinical Journal of the American Society of Nephrology, 2007
- IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the uglyKidney International, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004